Dermira, Inc.

( )
DERM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. -0.52%67.001.0%$983.90m
BIIBBiogen, Inc. -1.29%336.641.5%$675.10m
AMGNAmgen, Inc. -0.37%222.141.3%$548.39m
ILMNIllumina, Inc. -0.90%300.463.5%$422.01m
REGNRegeneron Pharmaceuticals, Inc. -0.42%399.142.6%$354.39m
VRTXVertex Pharmaceuticals, Inc. -1.08%245.101.9%$342.13m
ALXNAlexion Pharmaceuticals, Inc. -0.65%102.542.0%$217.31m
EXASEXACT Sciences Corp. 0.12%102.6424.0%$164.81m
AAgilent Technologies, Inc. -1.20%84.331.6%$163.24m
SGENSeattle Genetics, Inc. -1.30%118.336.1%$114.76m
INCYIncyte Corp. 0.43%82.772.5%$114.25m
MRNAModerna, Inc. -2.01%18.540.0%$106.77m
ALNYAlnylam Pharmaceuticals, Inc. 3.19%133.128.7%$94.43m
XLRNAcceleron Pharma, Inc. 0.43%94.856.1%$94.15m
BMRNBioMarin Pharmaceutical, Inc. -0.23%89.664.3%$88.88m

Company Profile

Dermira, Inc. is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.